TRANSCODE THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
TRANSCODE THERAPEUTICS, INC. (RNAZ) reported Basic Shares Outstanding (Weighted Average) of 957.19 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 957.19K shares, a 14.82% increase year-over-year.
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 916.97K shares, a 432.31% increase year-over-year.
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 913.06K shares, a 4218.29% increase year-over-year.
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 833.68K shares, a 5145.60% increase year-over-year.
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 689.71K shares, a 5392.22% increase from fiscal 2024.
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 12.56K shares, a 131.53% increase from fiscal 2023.
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 5.42K shares, a 66.56% decline from fiscal 2022.
- TRANSCODE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 16.22K shares, a 99.81% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 957.19K shares 10-Q · filed 2026-08-14 | 937.19K shares 10-Q · filed 2026-08-14 | 929.07K shares derived: average of 3 quarters · filed 2026-08-14 | 905.23K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 916.97K shares 10-Q · filed 2026-05-15 | 915.01K shares derived: average of 2 quarters · filed 2026-05-15 | 887.90K shares derived: average of 3 quarters · filed 2026-05-15 | 874.34K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 913.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 873.37K shares derived: average of 2 quarters · filed 2026-04-15 | 860.13K shares derived: average of 3 quarters · filed 2026-08-14 | 689.71K shares 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | 833.68K shares 10-Q · filed 2025-11-14 | 833.67K shares derived: average of 2 quarters · filed 2026-08-14 | 615.26K shares 10-Q · filed 2025-11-14 | 465.19K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 833.65K shares 10-Q · filed 2026-08-14 | 833.65K shares 10-Q · filed 2025-08-14 | 504.25K shares 10-Q · filed 2026-08-14 | 342.35K shares derived: average of 3 quarters · filed 2026-08-14 | 260.74K shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | 172.26K shares 10-Q · filed 2026-05-15 | 4.82M shares 10-Q · filed 2025-05-14 | 96.70K shares derived: average of 2 quarters · filed 2026-05-15 | 69.77K shares derived: average of 3 quarters · filed 2026-05-15 | 54.23K shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | 21.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 18.52K shares derived: average of 2 quarters · filed 2026-04-15 | 14.89K shares derived: average of 3 quarters · filed 2026-04-15 | 12.56K shares 10-K · filed 2026-04-15 | 356.12K shares 10-K · filed 2025-04-15 | |||
| 2024-09-30 | 15.89K shares 10-Q · filed 2025-11-14 | 14.69M shares 10-Q · filed 2024-11-14 | 11.76K shares derived: average of 2 quarters · filed 2025-11-14 | 9.70K shares 10-Q · filed 2025-11-14 | 8.96M shares 10-Q · filed 2024-11-14 | 10.64K shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 7.63K shares 10-Q · filed 2025-08-14 | 7.05M shares 10-Q · filed 2024-08-14 | 6.60K shares 10-Q · filed 2025-08-14 | 6.10M shares 10-Q · filed 2024-08-14 | 8.89K shares derived: average of 3 quarters · filed 2025-08-14 | 34.02K shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 155.83K shares 10-Q · filed 2025-05-14 | 5.14M shares 10-Q · filed 2024-05-15 | 9.51K shares derived: average of 2 quarters · filed 2025-05-14 | 42.81K shares derived: average of 3 quarters · filed 2025-05-14 | 39.73K shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -136.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -13.70K shares derived: average of 2 quarters · filed 2025-04-15 | 1.03K shares derived: average of 3 quarters · filed 2025-04-15 | 5.42K shares 10-K · filed 2025-04-15 | 179.01K shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 109.41K shares 10-Q · filed 2024-11-14 | 3.16M shares 10-Q · filed 2023-11-14 | 69.95K shares derived: average of 2 quarters · filed 2024-11-14 | 52.83K shares 10-Q · filed 2024-11-14 | 1.71M shares 10-Q · filed 2023-11-14 | -430.80K shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 30.49K shares 10-Q · filed 2024-08-14 | 1.32M shares 10-Q · filed 2023-08-14 | 24.54K shares 10-Q · filed 2024-08-14 | 1.02M shares 10-Q · filed 2023-08-14 | -610.87K shares derived: average of 3 quarters · filed 2024-08-14 | -295.94K shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 18.59K shares 10-Q · filed 2024-05-15 | 14.40M shares 10-Q · filed 2023-05-15 | -931.55K shares derived: average of 2 quarters · filed 2024-05-15 | -404.75K shares derived: average of 3 quarters · filed 2024-05-15 | -141.35K shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -1.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -616.42K shares derived: average of 2 quarters · filed 2024-04-01 | -194.66K shares derived: average of 3 quarters · filed 2024-04-01 | 16.22K shares 10-K · filed 2024-04-01 | 12.98M shares 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 648.86K shares 10-Q · filed 2023-11-14 | 12.98M shares 10-Q · filed 2022-11-14 | 648.86K shares derived: average of 2 quarters · filed 2023-11-14 | 648.86K shares 10-Q · filed 2023-11-14 | 12.98M shares 10-Q · filed 2022-11-14 | 6.79M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 648.86K shares 10-Q · filed 2023-08-14 | 12.98M shares 10-Q · filed 2022-08-15 | 648.86K shares 10-Q · filed 2023-08-14 | 12.98M shares 10-Q · filed 2022-08-15 | 8.84M shares derived: average of 3 quarters · filed 2023-08-14 | 9.51M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 12.98M shares 10-Q · filed 2023-05-15 | 12.94M shares derived: average of 2 quarters · filed 2023-05-15 | 12.47M shares derived: average of 3 quarters · filed 2023-05-15 | 10.51M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 12.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 12.22M shares derived: average of 2 quarters · filed 2023-03-31 | 9.69M shares derived: average of 3 quarters · filed 2023-03-31 | 8.43M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 11.53M shares 10-Q · filed 2022-11-14 | 8.08M shares derived: average of 2 quarters · filed 2022-11-14 | 6.93M shares 10-Q · filed 2022-11-14 | 6.36M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 4.64M shares 10-Q · filed 2022-08-15 | 4.64M shares 10-Q · filed 2022-08-15 | 4.64M shares derived: average of 3 quarters · filed 2022-08-15 | 4.64M shares derived: average of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | 4.64M shares 10-Q · filed 2022-05-16 | 4.64M shares derived: average of 2 quarters · filed 2022-05-16 | 4.64M shares derived: average of 3 quarters · filed 2022-05-16 | 4.64M shares derived: average of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | 4.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 4.64M shares derived: average of 2 quarters · filed 2022-03-31 | 4.64M shares derived: average of 3 quarters · filed 2022-03-31 | 4.64M shares 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 4.64M shares 10-Q · filed 2021-11-15 | 4.64M shares derived: average of 2 quarters · filed 2021-11-15 | 4.64M shares 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | 4.64M shares 10-Q · filed 2021-08-23 | 4.64M shares 10-Q · filed 2021-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |